Is ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) 3.6% ROE Worse Than Average?
On July 5th, 134 million restricted shares of Shu Yupingmin (301017.SZ) will be listed for circulation.
Shu Yuping Civilian (301017.SZ) announcement, the company's previously issued shares are actually available for listing before the initial public offering...
These 4 Measures Indicate That ShuYu Civilian Pharmacy (SZSE:301017) Is Using Debt In A Risky Way
Shuyu Pingmin (301017.SZ): Currently actively deploying cross-border e-commerce business
Gelonghui, May 28 | Shuyu Pingmin (301017.SZ) said on the investor interactive platform that the company is currently actively laying out cross-border e-commerce business to enhance the competitiveness of the company's products. The company's wholly-owned subsidiary in Hong Kong, China, Suyu Cross-border Shopping (Hong Kong) Co., Ltd. and Reiwa Shoji Co., Ltd., a wholly-owned subsidiary in Japan, are carriers of the company's cross-border e-commerce business, improving the company's cross-border e-commerce overseas products and providing consumers with richer products.
There Are Reasons To Feel Uneasy About ShuYu Civilian Pharmacy's (SZSE:301017) Returns On Capital
Shuyu Pingmin (301017.SZ): Accumulated investment of 42.97 million yuan to buy back 0.74% of shares
Gelonghui, May 20, 丨 Shuyu Ping Min (301017.SZ) announced that as of May 17, 2024, the company had repurchased 2,988,788 shares of the company's shares through a special stock repurchase account, accounting for 0.74% of the current total share capital. The highest transaction price was 15.50 yuan/share, the minimum transaction price was 11.91 yuan/share, and the total transaction amount was RMB 4,970,246.62 (excluding transaction fees). The company's current repurchase plan has been implemented and the period has expired. The actual time period for share repurchase is February 26 to 20, 2024
Shuyu Pingmin (301017.SZ): Net profit of 10.5082 million yuan in the first quarter decreased by 83.72% year on year
Gelonghui, April 26, 丨 Shu Yu Ping Min (301017.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 2,439 billion yuan, up 17.69% year on year; net profit attributable to shareholders of listed companies was 10.5082 million yuan, down 83.72% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 9.5085 million yuan, down 84.25% year on year; basic earnings per share were 0.03 yuan.
Shuyu Pingmin (301017.SZ): Currently, there are no sales of doughnut products
Gelonghui, April 10 | Shuyu Pingmin (301017.SZ) said on the investor interactive platform that the company currently has no sales of doughui products. The company's health food category covers a variety of nutritional supplements and functional foods to meet consumers' health needs.
ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Delivered A Better ROE Than Its Industry
Shuyu Pingmin (301017.SZ): Initial repurchase of 246,800 shares involving 3.620,900 yuan
Gelonghui, Feb. 26丨Shuyu Pingmin (301017.SZ) announced that on February 26, 2024, the company carried out its first repurchase through a centralized bidding transaction through a special securities account for share repurchases. The number of repurchases was 246.841 million shares, accounting for 0.06% of the current total share capital. The highest transaction price was 14.73 yuan/share, the lowest transaction price was 14.37 yuan/share, and the total transaction amount was RMB 3,6209.37 million (excluding transaction fees).
Shuyu Pingmin (301017.SZ): Plans to spend 40 million yuan to 60 million yuan to buy back the company's shares
Gelonghui, Feb. 19: Shuyu Pingmin (301017.SZ) announced that the company plans to use its own funds to repurchase some of the RMB common stock (A shares) shares already issued by the company through centralized bidding transactions. The repurchased shares are used to protect the company's value and shareholders' rights, and all of the repurchased shares will be sold in accordance with relevant regulations. The total amount of the repurchase capital is not less than RMB 40 million (inclusive) and not more than RMB 60 million (inclusive). The specific amount of shares to be repurchased is based on the actual repurchase amount when the repurchase is completed. The source of the repurchase funds is the company's own funds. The repurchase price is not more than 18 yuan
Shuyu Pingmin (301017.SZ) awarded 605,000 restricted shares to 32 incentive recipients at a price of 8.675 yuan/share
Shuyu Pingmin (301017.SZ) issued an announcement. The company determined February 7, 2024 as the reservation grant date (...
Is ShuYu Civilian Pharmacy (SZSE:301017) Using Too Much Debt?
Return Trends At ShuYu Civilian Pharmacy (SZSE:301017) Aren't Appealing
Matters relating to the termination of the sale of shares in a subsidiary to Shuyu Civic (600535.SH)
Tasly (600535.SH) issued an announcement. The 8th board of directors meeting of the company was held on September 25, 2023...
Guojin Securities: The outflow of medical prescriptions is accelerating, and we are optimistic about the strongest companies, Hengqiang
Leading pharmaceutical companies have a higher degree of store compliance and stronger management capabilities. Because they are more supervised and trusted, they are expected to gain a larger share in the process of undertaking the outflow of prescriptions; leading companies have scale effects and are more advantageous in terms of brand, procurement and bargaining power, and logistics management level.
Guojin Securities: The outflow of prescriptions brings incremental space to the industry, optimistic about leading retail pharmacies
Prescription outflow, also known as prescription distribution, refers to the act of patients diagnosing and treating a disease in a hospital. After the doctor prescribes drugs according to the treatment plan, they do not distribute prescriptions at the hospital pharmacy, but choose to distribute prescriptions at social pharmacies.
A Closer Look At ShuYu Civilian Pharmacy Corp., Ltd.'s (SZSE:301017) Impressive ROE
Li Wenjie, actual controller of Shuyu Pingmin (301017.SZ), and shareholder Qin Guangxia pledged a total of 33.25 million shares
Shu Yu Ping Min (301017.SZ) issued an announcement. The company recently received Li Wen, the company's controlling shareholder and actual controller...
Zhiyun Health (09955): The “Shuyu Civilian Pharmacy Smart SaaS Consultation System” case ranked in the 2023 “Fortune” Most Influential IoT Innovation List
Zhiyun Health (09955) issued an announcement. On November 9, 2023, the group built the “Shuyu Civilian Pharmacy...
No Data